Chan Li F, Metherell Louise A, Krude Heiko, Ball Colin, O'Riordan Stephen M P, Costigan Colm, Lynch Sally A, Savage Martin O, Cavarzere Paolo, Clark Adrian J L
Centre for Endocrinology, William Harvey Research Institute, St. Bartholomew's and The Royal London School of Medicine and Dentistry, London, UK.
Clin Endocrinol (Oxf). 2009 Aug;71(2):171-5. doi: 10.1111/j.1365-2265.2008.03511.x.
Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disease characterized by isolated glucocorticoid deficiency with preserved mineralocorticoid secretion. Mutations in the ACTH receptor (MC2R) account for approximately 25% of all FGD cases, but since these are usually missense mutations, a degree of receptor function is frequently retained. A recent report, however, suggested that disturbances in the renin-aldosterone axis were seen in some patients with potentially more severe MC2R mutations. Furthermore, MC2R knock out mice have overt aldosterone deficiency and hyperkalaemia despite preservation of a normal zona glomerulosa. We wished to determine whether a group of patients with severe nonsense mutations of the MC2R exhibited evidence of mineralocorticoid deficiency, thereby challenging the conventional diagnostic feature of FGD which might result in diagnostic misclassification.
Clinical review of patients with nonsense MC2R mutations.
Between 1993 and 2008, 164 patients with FGD were screened for mutations in the MC2R. Totally 42 patients (34 families) were found to have mutations in the MC2R. Of these, 6 patients (4 families) were found to have homozygous nonsense or frameshift mutations.
Mild disturbances in the renin-angiotensin-aldosterone axis were noted in four out of six patients, ranging from slightly elevated plasma renin levels to low aldosterone levels, although frank mineralocorticoid deficiency or electrolyte disturbance were not found. No patient required fludrocortisone replacement.
Severe nonsense and frameshift MC2R mutations are not associated with clinically significant mineralocorticoid deficiency and are thus unlikely to require long-term mineralocorticoid replacement.
家族性糖皮质激素缺乏症(FGD)是一种罕见的常染色体隐性疾病,其特征为单纯性糖皮质激素缺乏,而盐皮质激素分泌保留。促肾上腺皮质激素受体(MC2R)突变约占所有FGD病例的25%,但由于这些通常是错义突变,受体功能常得以保留。然而,最近一份报告表明,一些携带潜在更严重MC2R突变的患者出现了肾素 - 醛固酮轴紊乱。此外,MC2R基因敲除小鼠尽管球状带正常,但仍有明显的醛固酮缺乏和高钾血症。我们希望确定一组携带MC2R严重无义突变的患者是否表现出盐皮质激素缺乏的证据,从而对FGD的传统诊断特征提出质疑,因为这可能导致诊断错误分类。
对携带MC2R无义突变患者的临床回顾。
1993年至2008年间,对164例FGD患者进行了MC2R突变筛查。共发现42例患者(34个家系)存在MC2R突变。其中,6例患者(4个家系)被发现有纯合无义或移码突变。
6例患者中有4例出现肾素 - 血管紧张素 - 醛固酮轴轻度紊乱,从血浆肾素水平轻度升高到醛固酮水平降低,但未发现明显的盐皮质激素缺乏或电解质紊乱。无一例患者需要氟氢可的松替代治疗。
MC2R严重无义突变和移码突变与临床上显著的盐皮质激素缺乏无关,因此不太可能需要长期的盐皮质激素替代治疗。